Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer.
Jun Nyung LeeMi Young KimJae Hoon KangJun-Koo KangJae Wook ChungYun Sok HaSeock Hwan ChoiBum Soo KimHyun Tae KimTae Hwan KimEun Sang YooSee Hyung KimTae Gyun KwonPublished in: Investigative and clinical urology (2024)
PDT can delay progression of disease and enhance treatment efficacy with acceptable tolerability in oligoprogressive CRPC.